CompletedNot Applicable

Metaverse- and VR-Supported Education in the Digital Breastfeeding Museum: Effects on Knowledge, Self-Efficacy, Success

Turkey (Türkiye)53 participantsStarted 2023-07-01

Plain-language summary

This randomized controlled study aimed to evaluate the effect of Metaverse- and virtual reality (VR)-supported education provided in a digital breastfeeding museum on breastfeeding knowledge level, self-efficacy, and breastfeeding success in primiparous pregnant women. The study population consisted of primiparous women who applied for the first time to the antenatal classes of three hospitals in Turkey between July 2023 and April 2024 during their third trimester and had no prior breastfeeding experience. A total of 53 primiparous pregnant women were randomly assigned to the intervention group (n=28) and the control group (n=25). While the intervention group received Metaverse- and VR-supported breastfeeding education in the digital breastfeeding museum, the control group received standard antenatal education provided in routine antenatal classes. Data were collected using a questionnaire assessing participant satisfaction and breastfeeding knowledge, the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), and the LATCH Breastfeeding Assessment Tool. Assessments were performed at three time points: before the intervention, after the intervention, and postpartum.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primiparous pregnant women who have never given live birth or had any breastfeeding experience and who were attending antenatal classes for the first time during their third trimester, * Pregnant women who voluntarily agreed to participate in the study, * Pregnant women aged 18 years or older, * Pregnant women who are literate in Turkish, * Mothers who gave birth to newborns with normal gestational age and birth weight. Exclusion Criteria: * Pregnant women with physical conditions preventing them from breastfeeding, * Pregnant women with any condition that would prevent them from completing the questionnaire (e.g., intellectual disability, illiteracy), * Pregnant women who have difficulty communicating (e.g., with hearing, speech, or visual impairments), * Pregnant women with any illness that may affect milk secretion or breastfeeding (e.g., cancer, active tuberculosis), * Pregnant women taking medications that may interfere with breastfeeding, * Mothers whose newborns have conditions that could interfere with sucking (e.g., cleft lip/palate, being on mechanical ventilation, etc.).

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Breastfeeding Knowledge Score

Timeframe: Immediately before the education, immediately after the education, and within the first 24 hours postpartum

Breastfeeding Self-Efficacy Scale - Short Form (BSES-SF) Score

Timeframe: Immediately before the education, immediately after the education, and within the first 24 hours postpartum

LATCH Breastfeeding Assessment Tool Score

Timeframe: Within the first 24 hours postpartum

Trial details

NCT IDNCT07078825

SponsorUludag University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-30

View on ClinicalTrials.gov More Metaverse trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Breastfeeding Knowledge Score

Timeframe: Immediately before the education, immediately after the education, and within the first 24 hours postpartum

Breastfeeding Self-Efficacy Scale - Short Form (BSES-SF) Score

Timeframe: Immediately before the education, immediately after the education, and within the first 24 hours postpartum

LATCH Breastfeeding Assessment Tool Score

Timeframe: Within the first 24 hours postpartum